On May 24, 2020 the U.S. Centers for Disease Control (“CDC”) issued interim guidelines for COVID-19 antibody tests. The CDC states that data on serologic testing is “rapidly evolving” and “will have an important public health and clinical uses to
Leading insight on legal developments in the healthcare and life sciences industries.
On May 24, 2020 the U.S. Centers for Disease Control (“CDC”) issued interim guidelines for COVID-19 antibody tests. The CDC states that data on serologic testing is “rapidly evolving” and “will have an important public health and clinical uses to…